West Pharmaceutical Services, Inc. (WST)
392.15
-1.88
(-0.48%)
USD |
NYSE |
Oct 23, 16:00
391.72
-0.43
(-0.11%)
After-Hours: 20:00
West Pharmaceutical Services Enterprise Value : 27.49B for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 27.49B |
| October 22, 2026 | 27.62B |
| October 21, 2026 | 27.58B |
| October 20, 2026 | 27.25B |
| October 19, 2026 | 26.91B |
| October 16, 2026 | 26.92B |
| October 15, 2026 | 26.85B |
| October 14, 2026 | 26.26B |
| October 13, 2026 | 26.06B |
| October 12, 2026 | 25.76B |
| October 09, 2026 | 25.65B |
| October 08, 2026 | 25.45B |
| October 07, 2026 | 25.68B |
| October 06, 2026 | 26.11B |
| October 05, 2026 | 26.40B |
| October 02, 2026 | 25.58B |
| October 01, 2026 | 25.58B |
| September 30, 2026 | 25.98B |
| September 29, 2026 | 26.40B |
| September 28, 2026 | 26.33B |
| September 25, 2026 | 25.96B |
| September 24, 2026 | 26.18B |
| September 23, 2026 | 26.34B |
| September 22, 2026 | 26.01B |
| September 21, 2026 | 25.35B |
| Date | Value |
|---|---|
| September 18, 2026 | 25.39B |
| September 17, 2026 | 25.69B |
| September 16, 2026 | 25.37B |
| September 15, 2026 | 25.58B |
| September 14, 2026 | 24.89B |
| September 11, 2026 | 24.26B |
| September 10, 2026 | 24.12B |
| September 09, 2026 | 23.60B |
| September 08, 2026 | 23.66B |
| September 04, 2026 | 23.81B |
| September 03, 2026 | 24.01B |
| September 02, 2026 | 24.00B |
| September 01, 2026 | 23.72B |
| August 31, 2026 | 23.89B |
| August 28, 2026 | 23.64B |
| August 27, 2026 | 24.25B |
| August 26, 2026 | 24.52B |
| August 25, 2026 | 24.41B |
| August 24, 2026 | 24.75B |
| August 21, 2026 | 24.74B |
| August 20, 2026 | 24.79B |
| August 19, 2026 | 24.72B |
| August 18, 2026 | 24.28B |
| August 17, 2026 | 24.28B |
| August 14, 2026 | 24.48B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Globus Medical, Inc. | 10.45B |
| The Cooper Cos., Inc. | 14.03B |
| Becton, Dickinson & Co. | 70.12B |
| Hinge Health, Inc. | 8.560B |
| Stryker Corp. | 129.78B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 154.00M |
| Revenue (Quarterly) | 872.40M |
| Total Expenses (Quarterly) | 718.40M |
| EPS Diluted (Quarterly) | 2.160 |
| Gross Profit Margin (Quarterly) | 37.83% |
| Profit Margin (Quarterly) | 17.65% |
| Earnings Yield | 1.99% |
| Operating Earnings Yield | 2.58% |
| Normalized Earnings Yield | 2.097 |